Video

Experts Provide Insight on the Biggest Advances in Oncology in 2019

Author(s):

OncLive Staff

In Partnership With:

OncLive interviewed experts at the State of the Science Summits™ in December 2019 on what the biggest advances in oncology were in 2019.

OncLive interviewed experts at the State of the Science Summits™ in December 2019 on what the biggest advances in oncology were in 2019.

Related Videos
Patrick I. Borgen, MD, chair, Department of Surgery, Maimonides Medical Center; head, Maimonides Breast Center, Maimonides Cancer Center
Patrick I. Borgen, MD, chair, Department of Surgery, Maimonides Medical Center; head, Maimonides Breast Center, Maimonides Cancer Center
Elizabeth A. Brem, MD
Daniel DeAngelo, MD, PhD, discusses how the shift away from chemotherapy has affected the management of chronic lymphocytic leukemia.
Daniel DeAngelo, MD, PhD, discusses how the shift away from chemotherapy has affected the management of chronic lymphocytic leukemia.
Sandip P. Patel, MD
Pooja Phull, MD
Bhavana "Tina" Bhatnagar, DO
Ashkan Emadi, MD, PhD
Alexis LeVee, MD
Related Content
Sheela Rao, MBBS, MD, FRCP
January 7th 2025

Retifanlimab Emerges as Potential New SOC in Advanced SCAC

Paul J. Shaughnessy, MD, medical director, Adult Blood and Marrow Stem Cell Transplant Program, Methodist Hospital
November 28th 2024

FDA Approval Insights: Obe-Cel in B-Cell Precursor ALL

Armin Ghobadi, MD
January 7th 2025

WT-7 Shows Acceptable Safety Profile in Relapsed/Refractory T-ALL/LBL

Oncology Unplugged
November 6th 2024

Review Key Genitourinary Cancer Data From the 2024 ESMO Congress With Chandler Park, MD

Zolbetuximab Plus Chemotherapy in Gastric/GEJ Cancer | Image Credit: © Sebastian Kaulitzki – stock.adobe.com
January 6th 2025

Zolbetuximab Plus Chemo Wins Approval in China for CLDN18.2+ Advanced Gastric/GEJ Adenocarcinoma

Aparna Parikh, MD
January 5th 2025

Patient Factors Drive IO Combination Selection in Unresectable HCC